Norges Bank’s MiMedx Group MDXG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-70,400
Closed -$535K 1746
2025
Q1
$535K Sell
70,400
-347,500
-83% -$2.9M ﹤0.01% 1686
2024
Q4
$4.02M Buy
417,900
+347,500
+494% +$2.71M ﹤0.01% 1550
2024
Q3
$416K Hold
70,400
﹤0.01% 1798
2024
Q2
$488K Sell
70,400
-198,600
-74% -$1.4M ﹤0.01% 1880
2024
Q1
$2.07M Sell
269,000
-220,000
-45% -$1.77M ﹤0.01% 1734
2023
Q4
$4.29M Sell
489,000
-14,700
-3% -$108K ﹤0.01% 1698
2023
Q3
$3.67M Buy
+503,700
New +$3.75M ﹤0.01% 1737
2019
Q1
Sell
-401,297
Closed -$718K 2125
2018
Q4
$718K Sell
401,297
-1,099,592
-73% -$6.1M ﹤0.01% 2063
2018
Q3
$9.28M Hold
1,500,889
﹤0.01% 1837
2018
Q2
$9.59M Hold
1,500,889
﹤0.01% 1814
2018
Q1
$10.5M Buy
1,500,889
+291,706
+24% +$3.4M ﹤0.01% 1731
2017
Q4
$15.2M Buy
1,209,183
+303,550
+34% +$3.7M 0.01% 1582
2017
Q3
$10.8M Buy
+905,633
New +$13.4M ﹤0.01% 1713

Other funds holding MDXG

Norges Bank's MDXG Position: Q2 2025 in Review

Norges Bank sold out of MiMedx Group (MDXG) in Q2 2025, closing a stake of 70,400 shares — an estimated $535K sold.

Norges Bank first reported a position in MDXG in Q3 2017 and held it in 13 quarters. The position peaked at $15.2M in Q4 2017. 223 funds tracked by Wall St. Rank hold MDXG as of Q2 2025.

  • Norges Bank reported no remaining MiMedx Group position as of Q2 2025 after selling out during the quarter.
  • Norges Bank sold 70,400 MiMedx Group shares in Q2 2025, an estimated $535K.
  • Norges Bank first reported a position in MiMedx Group in Q3 2017 and held it in 13 quarters.
  • Norges Bank's MiMedx Group position peaked at $15.2M in Q4 2017.
  • 223 funds tracked by Wall St. Rank held MiMedx Group as of Q2 2025.

Based on Norges Bank's 13F filing for Q2 2025, filed 13 Aug 2025.